Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1234-1241
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1234
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1234
Table 1 General data, n (%)
Factors | Observation group (n = 42) | Control group (n = 40) | t/χ2 | P value |
Sex | 0.001 | 0.991 | ||
Male | 22 (52.38) | 21 (52.50) | ||
Female | 20 (47.62) | 19 (47.50) | ||
Age (yr) | 0.002 | 0.965 | ||
≤ 61 | 17 (40.48) | 16 (40.00) | ||
> 61 | 25 (59.52) | 24 (60.00) | ||
BMI (kg/m2) | 0.001 | 0.983 | ||
≤ 23 | 23 (54.76) | 22 (55.00) | ||
> 23 | 19 (45.24) | 18 (45.00) | ||
Mean course of disease (months) | 4.65 ± 0.85 | 4.82 ± 0.81 | 0.926 | 0.357 |
Hypertension | 0.001 | 0.991 | ||
Yes | 20 (47.62) | 19 (47.50) | ||
No | 22 (52.38) | 21 (52.50) | ||
Smoking history | 0.002 | 0.965 | ||
Yes | 25 (59.52) | 24 (60.00) | ||
No | 17 (40.48) | 16 (40.00) |
- Citation: Li JL, Zhao J, Guo ZF, Xiao C, Liu X. Efficacy of recombinant human epidermal growth factor plus sodium hyaluronate eye drops in diabetic dry eye post-cataract surgery. World J Diabetes 2024; 15(6): 1234-1241
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1234.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1234